Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report

Article date: October 2017

By: Willemien S. Kalteren, Marco W. J. Schreurs, Annelies Jorritsma‐Smit, Daan J. Touw, Jan Willem Jong, Petra G. M. A. Zweers, Fransje E. Reesink in Volume 83, Issue 10, pages 2330-2332

DOI: 10.1111/bcp.13338

View this article